These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
178 related items for PubMed ID: 32487603
21. Exosomal microRNA: a novel biomarker for breast cancer. He Y, Deng F, Yang S, Wang D, Chen X, Zhong S, Zhao J, Tang J. Biomark Med; 2018 Feb; 12(2):177-188. PubMed ID: 29151358 [Abstract] [Full Text] [Related]
22. Exosomal miRNA profile as complementary tool in the diagnostic and prediction of treatment response in localized breast cancer under neoadjuvant chemotherapy. Rodríguez-Martínez A, de Miguel-Pérez D, Ortega FG, García-Puche JL, Robles-Fernández I, Exposito J, Martorell-Marugan J, Carmona-Sáez P, Garrido-Navas MDC, Rolfo C, Ilyine H, Lorente JA, Legueren M, Serrano MJ. Breast Cancer Res; 2019 Feb 06; 21(1):21. PubMed ID: 30728048 [Abstract] [Full Text] [Related]
23. Simultaneous and multiplexed detection of exosome microRNAs using molecular beacons. Lee JH, Kim JA, Jeong S, Rhee WJ. Biosens Bioelectron; 2016 Dec 15; 86():202-210. PubMed ID: 27372573 [Abstract] [Full Text] [Related]
24. Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling. Zhang K, Wang YW, Wang YY, Song Y, Zhu J, Si PC, Ma R. Gene; 2017 Jul 01; 619():10-20. PubMed ID: 28359916 [Abstract] [Full Text] [Related]
25. A panel of serum exosomal microRNAs as predictive markers for chemoresistance in advanced colorectal cancer. Jin G, Liu Y, Zhang J, Bian Z, Yao S, Fei B, Zhou L, Yin Y, Huang Z. Cancer Chemother Pharmacol; 2019 Aug 01; 84(2):315-325. PubMed ID: 31089750 [Abstract] [Full Text] [Related]
26. Blood Circulating Exosomes Contain Distinguishable Fractions of Free and Cell-Surface-Associated Vesicles. Tamkovich S, Tutanov O, Efimenko A, Grigor'eva A, Ryabchikova E, Kirushina N, Vlassov V, Tkachuk V, Laktionov P. Curr Mol Med; 2019 Aug 01; 19(4):273-285. PubMed ID: 30868953 [Abstract] [Full Text] [Related]
28. Circulating microRNAs miR-331 and miR-195 differentiate local luminal a from metastatic breast cancer. McAnena P, Tanriverdi K, Curran C, Gilligan K, Freedman JE, Brown JAL, Kerin MJ. BMC Cancer; 2019 May 10; 19(1):436. PubMed ID: 31077182 [Abstract] [Full Text] [Related]
29. miRNA expression in breast cancer varies with lymph node metastasis and other clinicopathologic features. Wang B, Li J, Sun M, Sun L, Zhang X. IUBMB Life; 2014 May 10; 66(5):371-7. PubMed ID: 24846313 [Abstract] [Full Text] [Related]
31. CD97 promotes gastric cancer cell proliferation and invasion through exosome-mediated MAPK signaling pathway. Li C, Liu DR, Li GG, Wang HH, Li XW, Zhang W, Wu YL, Chen L. World J Gastroenterol; 2015 May 28; 21(20):6215-28. PubMed ID: 26034356 [Abstract] [Full Text] [Related]
34. Colorectal cancer-derived exosomal miR-106b-3p promotes metastasis by down-regulating DLC-1 expression. Liu H, Liu Y, Sun P, Leng K, Xu Y, Mei L, Han P, Zhang B, Yao K, Li C, Bai J, Cui B. Clin Sci (Lond); 2020 Feb 28; 134(4):419-434. PubMed ID: 32065214 [Abstract] [Full Text] [Related]
38. miR-142-3p as tumor suppressor miRNA in the regulation of tumorigenicity, invasion and migration of human breast cancer by targeting Bach-1 expression. Mansoori B, Mohammadi A, Ghasabi M, Shirjang S, Dehghan R, Montazeri V, Holmskov U, Kazemi T, Duijf P, Gjerstorff M, Baradaran B. J Cell Physiol; 2019 Jun 28; 234(6):9816-9825. PubMed ID: 30480817 [Abstract] [Full Text] [Related]